92 products were found matching "K11218"!

1 from 8 pages
No results were found for the filter!
COVID-19 Research
Tofacitinib
Tofacitinib

Item number: AG-CR1-3625-M005

Off-white to pale yellow solid. Soluble in DMSO or ethanol. Potent cell permeable JAK3 inhibitor (IC50 = 1nM). Shows also JAK-1 inhibitory activity, Immunosuppressive and anti-inflammatory agent, Inhibits signaling through heterodimeric receptors associated with JAK3, JAK1, or both of them, with functional...
Keywords: CP-690550, Xeljanz, Tasocitinib
Application: Cell-permeable JAK3 inhibitor
CAS 477600-75-2
MW: 312,4 D
From 77.00€ *
Review
Tofacitinib (citrate)
Tofacitinib (citrate)

Item number: Cay11598-5

Tofacitinib is a potent, cell-permeable inhibitor of all JAK isoforms (IC50s = 6.1, 12, and 8 nM for JAK1, JAK2, and JAK3, respectively). It is selective for JAK1-3 over ROCK2 and Lck (IC50s = 3,400 and 3,870 nM, respectively) as well as 28 additional kinases in enzyme assays (IC50s = >10,000 nM). It inhibits...
Keywords: Tofacitinib citrate,...
Application: JAK inhibitor
CAS 540737-29-9
MW: 504.5 D
From 102.00€ *
Review
VX-509
VX-509

Item number: Cay19513-1

VX-509 is a selective inhibitor of Janus kinase 3 (JAK3) with a Ki value of 2.5 nM in enzyme assays and an IC50 value of 50-170 nM in cellular assays dependent on JAK3 activity with no measurable activity against other JAK isotypes. At 10-100 mg/kg, it has been shown to dose dependently reduce proinflammatory...
Keywords: Decernotinib, VRT-831509,...
Application: JAK3 inhibitor
CAS 944842-54-0
MW: 392.4 D
From 54.00€ *
Review
WHI-P131
WHI-P131

Item number: Cay10011246-10

Janus kinase 3 (JAK3) is a cytoplasmic protein tyrosine kinase that functions in the initiation of cytokine-triggered signal transduction by catalyzing the phosphorylation of signal transduction and activators of transcription (STATs). JAK3 is abundantly expressed in normal lymphoid cells as well as human...
Keywords: Janex 1, 4-[(6,7-dimethoxy-4-quinazolinyl)amino]-phenol
Application: JAK3 inhibitor
CAS 202475-60-3
MW: 297.3 D
From 48.00€ *
Review
ZM 39923 (hydrochloride)
ZM 39923 (hydrochloride)

Item number: Cay16729-1

ZM 39923 is an inhibitor of JAK3 (IC50 = 79 nM) that less potently inhibits epidermal growth factor receptor, JAK1, and cyclin-dependent kinase 4 (IC50s = 2.4, 40, and 10 µM, respectively). In the absence of the reducing agent dithiothreitol, ZM 39923 also inhibits human tissue transglutaminase 2 (TGM2) and the...
Keywords: JAK3 Inhibitor IV, Janus-Associated Kinase 3 Inhibitor IV,...
Application: JAK3 inhibitor
CAS 1021868-92-7
MW: 367.9 D
From 67.00€ *
Review
FM-381
FM-381

Item number: Cay23204-1

FM-381 is a potent inhibitor of JAK3 (IC50 = 127 pM). It is 400-, 2,700-, and 3,600-fold selective for JAK3 over JAK1, JAK2, and TYK3 and only inhibits 11 kinases by less than 50 percent in a panel of 410 kinases when used at a concentration of 500 nM. FM-381 (1 µM) blocks JAK3-dependent STAT5 phosphorylation but...
Keywords: (E)-2-cyano-3-(5-(1-cyclohexyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2-yl)furan-2-yl)-N,N-dimethylacrylamide
Application: Potent JAK3 inhibitor
MW: 428.5 D
From 67.00€ *
Review
Decernotinib
Decernotinib

Item number: LKT-D364086.5

JAK3 inhibitor.
Keywords: VX-509, VRT-831509, Adelitinib
Application: JAK3 inhibitor
CAS 944842-54-0
MW: 392.39 D
From 123.00€ *
Review
Tofacitinib . citrate
Tofacitinib . citrate

Item number: AG-CR1-3732-M005

White to off-white solid. Soluble in DMSO (20mg/ml) or DMF (5mg/ml). Slightly soluble in ethanol or water. Chemical. CAS: 540737-29-9. Formula: C16H20N6O . C6H8O7. MW: 312.4 . 192.1. Potent cell permeable JAK3 inhibitor (IC50 = 1nM). Shows also JAK-1 inhibitory activity. Immunosuppressive and anti-inflammatory...
Keywords: CP-690550, Xeljanz, Tasocitinib
Application: JAK3 inhibitor
CAS 540737-29-9
MW: 504,5 D
From 55.00€ *
Review
TCS 21311
TCS 21311

Item number: Cay30063-5

TCS 21311 is an inhibitor of JAK3 (IC50 = 8 nM in an enzyme assay). It is selective for JAK3 over JAK1, JAK2, and tyrosine kinase 2 (TYK2, IC50s = 1,017, 2,550, and 8,055 nM, respectively) but does inhibit glycogen synthase kinase 3beta (GSK-3beta), PKCalpha, and PKCtheta (IC50s = 13, 68, and 3 nM, respectively)....
Keywords: NIBR3049,...
Application: JAK3 inhibitor
CAS 1260181-14-3
MW: 526.5 D
From 85.00€ *
Review
PF-06651600
PF-06651600

Item number: Cay21054-10

PF-06651600 is a covalent inhibitor of JAK3 (IC50 = 33.1 nM). It is selective for JAK3 over JAK1, JAK2, and tyrosine kinase 2 (TYK2, IC50s = >10,000 for all) and a panel of 304 other kinases at 1 µM. PF-06651600 inhibits STAT5, STAT6, and STAT3 phosphorylation induced by IL-2, IL-4, or IL-21, respectively, in...
Keywords: Ritlecitinib, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-2-propen-1-one
Application: Covalent JAK3 inhibitor
CAS 1792180-81-4
MW: 285.3 D
From 123.00€ *
Review
JAK3-IN-6
JAK3-IN-6

Item number: TGM-T5492-2mg

Description: JAK3-IN-6 is irreversible Janus Associated Kinase 3 (JAK3) inhibitor, with an IC50 of 0.15 nM. Target: JAK. Smiles: CCOC(=O)c1c[nH]c2ncnc(-c3cccc(NC(=O)C(C)=C)c3)c12. References: Elwood F, et al. Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor. J...
Application: JAK3 inhibitor
CAS 1443235-95-7
MW: 350.37 D
From 33.00€ *
Review
MS-1020
MS-1020

Item number: AG-CR1-3501-M001

Selective JAK3 inhibitor, Blocks STAT signaling, Inducer of apoptosis via down-regulation of anti-apoptotic gene expression.
Keywords: 1-Hydroxy-N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)-2-naphtamide
Application: JAK3 inhibitor
MW: 346,4 D
72.00€ *
Review
1 from 8 pages